FuXion Biotech

fuxion.com

Somos una empresa multinacional líder en la industria del bienestar con presencia en más de 12 países en todo el continente. Desde 2004 estamos comprometidos en brindar alternativas saludables que acompañan a las personas en todas las etapas de su vida de forma integral, a la cual llamamos "Salud Verdadera" Ofrecemos un concepto único al que llamamos Fusión Nutraceutica. Mezclando tecnología de punta con conocimientos milenarios, nuestros productos brindan a cada una de las células del cuerpo la cantidad adecuada de nutrientes que necesita para alcanzar un estado de salud plena.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

SARTORIUS STEDIM BIOTECH CLOSES ACQUISITION OF SLOVENIAN PURIFICATION SPECIALIST BIA SEPARATIONS

Sartorius | November 03, 2020

news image

Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the required approvals. "BIA's portfolio is highly complementary to Sartorius Stedim Biotech. We are thus creating an excellent offering for the manufacturing of gene therapies and other advanced therapies, and are pleased to welcome 120 new employees,&...

Read More

ADAPTIVE BIOTECHNOLOGIES AND MICROSOFT EXPAND PARTNERSHIP TO DECODE COVID-19 IMMUNE RESPONSE AND PROVIDE OPEN DATA ACCESS

BioSpace | March 20, 2020

news image

Adaptive Biotechnologies Corp. (Nasdaq: ADPT) and Microsoft Corp. (Nasdaq: MSFT) on Friday announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19. Finding the relevant immune response signature may advance solutions to diagnose, treat and prevent the disease, augmenting existing research efforts that primarily focus on the biology of the virus. These data will be made freely available to any researcher, pub...

Read More

Diagnostics

ZOETIS TO COMPLETE ACQUISITION OF BASEPAWS TO STRENGTHEN ITS PORTFOLIO

Zoetis | June 27, 2022

news image

Zoetis Inc. is the world's largest animal health company committed to providing medicine and vaccinations for pets and livestock. The company announced completing the acquisition of a privately held petcare genetics company, Basepaws, which offers early health risk assessments, genetic tests, and analytics to pet owners. The acquisition was first announced on June 7th. However, the financial terms of the purchase were not disclosed. Basepaws, founded by CEO Anna Skaya in 2017,...

Read More

Industrial Impact, Medical

BICYCLE THERAPEUTICS ANNOUNCES A STRATEGIC COLLABORATION WITH NOVARTIS TO DISCOVER, DEVELOP AND COMMERCIALIZE BICYCLE® RADIO-CONJUGATES

Businesswire | March 29, 2023

news image

Bicycle Therapeutics plc a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a strategic collaboration agreement with Novartis to develop, manufacture and commercialize Bicycle® radio-conjugates (BRCs) for multiple agreed upon oncology targets. “This collaboration builds on the groundbreaking clinical work we have been doing in the...

Read More
news image

SARTORIUS STEDIM BIOTECH CLOSES ACQUISITION OF SLOVENIAN PURIFICATION SPECIALIST BIA SEPARATIONS

Sartorius | November 03, 2020

Sartorius Stedim Biotech (SSB), a leading partner of the biopharma industry, successfully closed the acquisition of the Slovenian purification specialist BIA Separations. The transaction was completed on November 2, 2020, after receiving the required approvals. "BIA's portfolio is highly complementary to Sartorius Stedim Biotech. We are thus creating an excellent offering for the manufacturing of gene therapies and other advanced therapies, and are pleased to welcome 120 new employees,&...

Read More
news image

ADAPTIVE BIOTECHNOLOGIES AND MICROSOFT EXPAND PARTNERSHIP TO DECODE COVID-19 IMMUNE RESPONSE AND PROVIDE OPEN DATA ACCESS

BioSpace | March 20, 2020

Adaptive Biotechnologies Corp. (Nasdaq: ADPT) and Microsoft Corp. (Nasdaq: MSFT) on Friday announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19. Finding the relevant immune response signature may advance solutions to diagnose, treat and prevent the disease, augmenting existing research efforts that primarily focus on the biology of the virus. These data will be made freely available to any researcher, pub...

Read More
news image

Diagnostics

ZOETIS TO COMPLETE ACQUISITION OF BASEPAWS TO STRENGTHEN ITS PORTFOLIO

Zoetis | June 27, 2022

Zoetis Inc. is the world's largest animal health company committed to providing medicine and vaccinations for pets and livestock. The company announced completing the acquisition of a privately held petcare genetics company, Basepaws, which offers early health risk assessments, genetic tests, and analytics to pet owners. The acquisition was first announced on June 7th. However, the financial terms of the purchase were not disclosed. Basepaws, founded by CEO Anna Skaya in 2017,...

Read More
news image

Industrial Impact, Medical

BICYCLE THERAPEUTICS ANNOUNCES A STRATEGIC COLLABORATION WITH NOVARTIS TO DISCOVER, DEVELOP AND COMMERCIALIZE BICYCLE® RADIO-CONJUGATES

Businesswire | March 29, 2023

Bicycle Therapeutics plc a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that it has entered into a strategic collaboration agreement with Novartis to develop, manufacture and commercialize Bicycle® radio-conjugates (BRCs) for multiple agreed upon oncology targets. “This collaboration builds on the groundbreaking clinical work we have been doing in the...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us